CAS 2247995-37-3

2247995-37-3

Description:

The chemical substance with the identifier "2247995-37-3" is not widely recognized in public databases or literature, which may indicate that it is a relatively new compound, a specialized research chemical, or a substance not yet characterized in detail. Typically, substances are identified by their CAS (Chemical Abstracts Service) numbers, which provide a unique identifier for chemical compounds. Characteristics of a chemical substance generally include its molecular formula, structure, physical properties (such as melting point, boiling point, solubility, and density), and potential applications or uses in various fields like pharmaceuticals, materials science, or agriculture. To obtain specific information about this compound, including its safety data, reactivity, and potential hazards, it is advisable to consult specialized chemical databases, scientific literature, or safety data sheets (SDS) provided by manufacturers or research institutions. If this compound is under investigation or proprietary, detailed information may be limited or subject to confidentiality.

Formula: C₃₀H₃₄N₈O₃·CH₄O₃S

Synonyms:

• Lazertinib Methanesulfonic acid
• 2-Propenamide, N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]-2-pyrimidinyl]amino]-4-methoxy-2-(4-morpholinyl)phenyl]-, methanesulfonate (1:1)

Lazertinib mesylate

CAS: 2247995-37-3

Lazertinib (mesylate) (YH25448 (mesylate); GNS-1480 (mesylate)) is an orally active EGFR inhibitor capable of crossing the blood-brain barrier. It suppresses the p-EGFR, p-AKT, and p-ERK signaling pathways, leading to apoptosis. Lazertinib (mesylate) demonstrates antitumor activity in the H1975-luc BM xenograft model in mice and is applicable for researching non-small cell lung cancer.

Formula: C₃₁H₃₈N₈O₆S

Molecular weight: 650.75

Ref: TM-T207270